Cidara Therapeutics, Inc. (CDTX) Social Stream



Cidara Therapeutics, Inc. (CDTX): $11.62

0.08 (-0.68%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add CDTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#53 of 347

in industry

CIDARA THERAPEUTICS INC (CDTX) Price Targets From Analysts

Use the tables below to see what analysts covering CIDARA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-22 5 $8 $5 $5.85 $0.782 648.08%
2021-12-03 6 $8 $5 $5.875 $0.782 651.28%
2021-12-15 6 $8 $5 $6.125 $0.782 683.25%
2022-03-30 6 $8 $5 $6.291 $0.782 704.48%
2022-04-08 6 $8 $3 $5.958 $0.782 661.89%
2022-06-01 6 $8 $3 $5.708 $0.782 629.92%
2022-08-11 5 $8 $3 $5.65 $0.782 622.51%
2022-11-07 4 $8 $3 $5.5 $0.782 603.32%
2023-03-08 4 $8 $3 $5.625 $0.782 619.31%
2023-03-24 3 $8 $5 $6.333 $0.782 709.85%
2023-05-15 3 $8 $3 $5.5 $0.782 603.32%
2023-11-06 3 $6 $3 $4.5 $0.782 475.45%

The Trend in the Analyst Price Target


CDTX's average price target has moved down $1.79 over the prior 21 months.

Over the past 41 weeks, CDTX's average upside potential has been 377.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-08 4 8 3 5.625 1.61 249.38%
2023-03-24 2 8 3 5.500 1.16 374.14%
2023-03-24 3 8 3 5.500 1.16 374.14%
2023-04-18 3 8 3 5.500 1.13 386.73%
2023-05-15 3 8 3 5.500 1.36 304.41%

CDTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

The Trend in the Broker Recommendations


Over the past 35 weeks, CDTX's average broker recommendation rating worsened by 0.33.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CDTX has a greater upside potential (average analyst target price relative to current price) than 1809.3% of all US stocks.
  • CIDARA THERAPEUTICS INC's average analyst price target is greater than 93.48% of all US stocks.
  • CIDARA THERAPEUTICS INC's number of analysts covering the stock is greater than 1440.4% of stocks in the micro market cap category.
  • In terms of how CIDARA THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -1345.29% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CIDARA THERAPEUTICS INC are TARA, TCON, and FENC.

What is the outlook for CDTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!